Dyadic Logo Current.jpg
Dyadic to Attend Industry and Investor Events in May
08 mai 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
22157.jpg
Infectious Vaccine Collaboration, Development, Research and Licensing Deals Trends Report 2024 with Directory of 522 Agreements Signed Since 2019
07 mai 2024 06h37 HE | Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Infectious Vaccine...
Global Vaccine Delivery Devices Market
Global Vaccine Delivery Devices Market Report 2024-2032: Device, Route of Administration, End User, and Regional Analysis and Forecasts
07 mai 2024 05h24 HE | Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Delivery Devices Market Report by Device, Route of Administration, End User, and Region 2024-2032" report has been added to ...
New Logo.png
Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)
02 mai 2024 08h00 HE | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, May 02, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office has...
Global Anti-Venom Market
Global Anti-Venom Analysis Report 2024: A $1.95 Billion Market by 2032 Featuring BSV, Boehringer Ingelheim, Boston Scientific, CSL, Merck, Pfizer, Haffkine Bio-Pharmaceutical
30 avr. 2024 10h37 HE | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-Venom Market Report by Type, Animal Type, End User, Region and Company Analysis 2024-2032" report has been added to ...
22157.jpg
Pfizer's ABRYSVO (RSVpreF) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032
30 avr. 2024 04h40 HE | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "ABRYSVO Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032
30 avr. 2024 04h34 HE | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Global COVID-19 Vaccines Research Report 2023-2025 - Licensing and Partnership Deals Worldwide Propel Vaccine Production
22 avr. 2024 06h22 HE | Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Vaccines Market to...
walgreens (Facebook Post)
Foundation for Sarcoidosis Research and Walgreens Unite in Alabama to Boost Sarcoidosis Awareness and Spring Vaccine Education for April Awareness Month
15 avr. 2024 18h31 HE | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research Partners with Walgreens in Alabama to Raise Awareness for Sarcoidosis and Spring Vaccines
Vaccine Adjuvant Market
Global Vaccine Adjuvant Market Forecasted to Reach USD 6.93 Billion by 2028
01 avr. 2024 18h06 HE | Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvant Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class, Type,...